特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

小児ワクチンの世界市場:成長、動向、予測(2019~2024年)

Pediatric Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 824070
出版日 ページ情報 英文 113 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
小児ワクチンの世界市場:成長、動向、予測(2019~2024年) Pediatric Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年10月01日 ページ情報: 英文 113 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

世界の小児ワクチン市場は2019~2024年にかけてCAGR11.7%で拡大すると予測されています。予防接種の重要性とその認識とともに、慢性疾患の負担増大、ワクチン技術の進歩、政府や非政府機関の研究開発への資金援助などが市場の成長に貢献しています。

当レポートでは、世界の小児ワクチン市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場動向

  • 市場概要
  • 市場促進因子
    • 慢性疾患の負担増大と予防接種の重要性と認識
    • ワクチンの技術進歩
    • 政府、非政府機関の研究開発への資金援助
  • 市場阻害因子
    • 予防接種コスト
    • 低~中所得国における医療サービスと医療補償程度の低さ
  • ポーターズファイブフォース分析

第5章 市場セグメンテーション

  • ワクチンタイプ別
    • 一価
    • 多価
  • 技術別
    • 生ワクチン
    • 不活化ワクチン
    • トキソイドワクチン
    • 共役ワクチン
    • その他
  • 用途別
    • 感染症
    • アレルギー
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合動向

  • 企業プロファイル
    • GlaxoSmithKline PLC
    • Indian Immunologicals Limited
    • AstraZeneca
    • Merck & Co. Inc.
    • 田辺三菱製薬株式会社
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Seqirus (CSL Limited)

第7章 市場の機会と将来動向

目次
Product Code: 64990

Market Overview

The global pediatric vaccine market is expected to register 11.7% CAGR during the forecast period 2019-2024. The growth of the pediatric vaccines market is attributed due to the rising burden of chronic disease with the importance and awareness of immunization, technological advancements in vaccines, an increase in the government and non-government funding in R&D.

As immunization plays a significant role in modern medicine, there are several international programs for children, which may vary based on the disease. However, these programs are primarily driving the demand for the pediatric vaccines market.

There are several chronic diseases among children, which make them further susceptible to severe manifestations and complications with chronic diseases, For example, diseases, such as allergic, cardiorespiratory, hematologic, metabolic, and renal disorders, among others, lead to an increased risk of developing influenza, varicella, and pneumococcal infection. The parental understanding regarding these complications and immunization benefits is also required to raise awareness regarding pediatric vaccines. The television, by far, is the most common source of information, followed by health professionals, newspapers, and magazines. The uptake of pediatric vaccination has improved through community-based vaccination program, which communicates the benefits and effectiveness of vaccines, hence promoting the growth of the pediatric vaccines market.

Furthermore, government initiatives, like Vaccines for Children Program, provides vaccines to children who lack health insurance or cannot afford the cost of vaccination, which is funded by the Centers for Medicare and Medicaid Services (CMS) to the Centers for Disease Control (CDC), and approved by the Office of Management and Budget.

Scope of the Report

As per the scope of the report, pediatric vaccines are vaccines that stimulate the body's immune response, in order to prevent a specific disease in children.

Key Market Trends

The Conjugate Vaccine Segment, under Technology, is Expected to Grow at the Fastest Rate, during the Forecast Period

The conjugate vaccine segment held a maximum share in 2018, and is likely to witness a rapid growth during the forecast period, due to the increasing prevalence of pneumococcal and meningococcal infections, and rise in the awareness regarding the prevention of infection, by government initiatives.

The North American Region Holds the Largest Market Share of the Pediatric Vaccines Market and is Projected to Follow the Same Trend over the Forecast Period

North America is expected to be the primary region for the pediatric vaccines market, over the forecast period. The scheduled children immunization programs under the Centers for Disease Control and Prevention (CDC), high funding, wide commercial availability of vaccines, and the awareness in society regarding vaccines contribute to the sustained growth in the United States. In Canada, the vaccination schedule for infants and children are regularly updated by the Government of Canada, in collaboration with the Canadian Nursing Coalition for Immunization (CNCI) and the Canadian Immunization Committee (CIC). The well-structured healthcare services boost the growth of the pediatric vaccines market in North America.

Competitive Landscape

The pediatric vaccines market consists of several major players, including GlaxoSmithKline PLC, Merck & Co. Inc., Novartis AG, etc. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases with the Importance and Awareness of Immunization
    • 4.2.2 Technological Advancements in Vaccines
    • 4.2.3 Increase in the Government and Non-government Funding in R&D
  • 4.3 Market Restraints
    • 4.3.1 Cost of Immunization
    • 4.3.2 Low Medical Coverage and Healthcare Services in Low- and Middle-income Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Vaccine Type
    • 5.1.1 Monovalent
    • 5.1.2 Multivalent
  • 5.2 By Technology
    • 5.2.1 Live Attenuated
    • 5.2.2 Inactivated
    • 5.2.3 Toxoid
    • 5.2.4 Conjugate
    • 5.2.5 Other Technologies
  • 5.3 By Application
    • 5.3.1 Infectious Disease
    • 5.3.2 Cancer
    • 5.3.3 Allergy
    • 5.3.4 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GlaxoSmithKline PLC
    • 6.1.2 Indian Immunologicals Limited
    • 6.1.3 AstraZeneca
    • 6.1.4 Merck & Co. Inc.
    • 6.1.5 Mitsubishi Tanabe Pharma Corporation
    • 6.1.6 Novartis AG
    • 6.1.7 Pfizer Inc.
    • 6.1.8 Sanofi SA
    • 6.1.9 Seqirus (CSL Limited)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS